Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Björhall K"'
Autor:
Hamblet C; Bioscience Chronic Obstructive Pulmonary Disease & Idiopathic Pulmonary Fibrosis, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden., Björhall K; Bioscience Chronic Obstructive Pulmonary Disease & Idiopathic Pulmonary Fibrosis, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden., Busch S; Respiratory & Immunology, Neuroscience, Vaccines and Immune Therapies Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, 431 83 Mölndal, Sweden., Gehrmann U; Translational Science and Experimental Medicine Research, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden., Öberg L; Translational Science and Experimental Medicine Research, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden., Kubisch-Dohmen R; ETHRIS GmbH, 82152 Planegg, Germany., Haas S; ETHRIS GmbH, 82152 Planegg, Germany., Aneja MK; ETHRIS GmbH, 82152 Planegg, Germany., Geiger J; ETHRIS GmbH, 82152 Planegg, Germany., Rudolph C; ETHRIS GmbH, 82152 Planegg, Germany., Hornberg E; Projects and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, 431 83 Mölndal, Sweden.
Publikováno v:
Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2024 Jul 30; Vol. 13 (8). Date of Electronic Publication: 2024 Jul 30.
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics April 2012 80(3):630-637
Autor:
Mattsson J; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Israelsson E; Translational Science and Experimental Medicine Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Björhall K; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Yrlid LF; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Thörn K; Translational Science and Experimental Medicine Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Thorén A; Animal Science and Technologies Clinical Pharmacology & Safety Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Toledo EA; Animal Science and Technologies Clinical Pharmacology & Safety Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Jinton L; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Öberg L; Translational Science and Experimental Medicine Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Wingren C; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Tapani S; Early Biometrics & Statistical Innovation Data Science & AI BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Jackson SG; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Skogberg G; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Lundqvist AJ; Drug Metabolism & Pharmacokinetics Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Hendrickx R; Drug Metabolism & Pharmacokinetics Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Cavallin A; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Österlund T; The Discovery Sciences Unit BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Grimster NP; Chemistry Oncology R&D AstraZeneca Waltham Massachusetts USA., Nilsson M; Medicinal Chemistry BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden., Åstrand A; Bioscience, Research and Early Development Respiratory & Immunology (R&I) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.
Publikováno v:
Skin health and disease [Skin Health Dis] 2023 Jan 29; Vol. 3 (3), pp. e209. Date of Electronic Publication: 2023 Jan 29 (Print Publication: 2023).
Autor:
Perry MWD; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Björhall K; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Bold P; DMPK, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Brűlls M; Early Product Development & Manufacturing, Pharmaceutical Sciences R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Börjesson U; Computational Chemistry, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Carlsson J; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Chang HA; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Chen Y; Pharmaron Beijing Co., Ltd., No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Eriksson A; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Fihn BM; DMPK, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Fransson R; Advanced Drug Delivery, Pharmaceutical Sciences R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Fredlund L; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Ge H; Pharmaron Beijing Co., Ltd., No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Huang H; Pharmaron Beijing Co., Ltd., No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Karabelas K; Projects, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Lamm Bergström E; DMPK, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Lever S; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Lindmark H; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Mogemark M; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Nikitidis A; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Palmgren AP; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Pemberton N; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Petersen J; Structure & Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Rodrigo Blomqvist M; Bioscience Cough and In Vivo, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Smith RW; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Thomas MJ; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Ullah V; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Tyrchan C; Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Wennberg T; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Westin Eriksson A; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Yang W; Pharmaron Beijing Co., Ltd., No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Zhao S; Pharmaron Beijing Co., Ltd., No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Öster L; Structure & Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Jun 24; Vol. 64 (12), pp. 8053-8075. Date of Electronic Publication: 2021 Jun 03.
Autor:
Fochtman, Daniel1 (AUTHOR), Marczak, Lukasz1 (AUTHOR), Pietrowska, Monika2 (AUTHOR), Wojakowska, Anna1 (AUTHOR) astasz@ibch.poznan.pl
Publikováno v:
Journal of Extracellular Vesicles. Dec2024, Vol. 13 Issue 12, p1-22. 22p.
Autor:
Perry MWD; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Björhall K; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Bonn B; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Carlsson J, Chen Y; Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Eriksson A; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Fredlund L, Hao H; Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Holden NS; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Karabelas K; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Lindmark H, Liu F; Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Pemberton N; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Petersen J, Rodrigo Blomqvist S; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Smith RW; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Svensson T; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Terstiege I; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Tyrchan C; Respiratory, Inflammation and Autoimmunity, Innovative Medicines and Early Development, AstraZeneca Gothenburg , Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Yang W; Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Zhao S; Pharmaron Beijing Co., Ltd. , No. 6 Taihe Road, BDA, Beijing 100176, P.R. China., Öster L
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Jun 22; Vol. 60 (12), pp. 5057-5071. Date of Electronic Publication: 2017 Jun 07.
Autor:
Pinkerton, James W.1,2 (AUTHOR), Preite, Silvia1 (AUTHOR), Piras, Antonio1 (AUTHOR), Zervas, Dimitrios1,2 (AUTHOR), Markou, Thomais1,2 (AUTHOR), Freeman, Mark S.1,2 (AUTHOR), Hofving, Tobias1 (AUTHOR), Ivarsson, Emil1 (AUTHOR), Bonvini, Sara J.1,2 (AUTHOR), Brailsford, Wayne1 (AUTHOR), Yrlid, Linda1 (AUTHOR), Belvisi, Maria G.1,2 (AUTHOR), Birrell, Mark A.1,2 (AUTHOR) mark.birrell@astrazeneca.com
Publikováno v:
Respiratory Research. 4/23/2024, Vol. 25 Issue 1, p1-10. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hillström A; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden. anna.hillstrom@slu.se., Bylin J; Evidensia Södra Djursjukhuset, Stockholm, Sweden., Hagman R; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden., Björhall K; Department of Translational Sciences, RIA IMed, AstraZeneca R&D Mölndal, Mölndal, Sweden., Tvedten H; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden., Königsson K; Safety Assessment, AstraZeneca R&D Södertälje, Södertälje, Sweden., Fall T; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kjelgaard-Hansen M; Translational Haemophilia Pharmacology, Novo Nordisk, Maaloev, Denmark.
Publikováno v:
BMC veterinary research [BMC Vet Res] 2016 Oct 28; Vol. 12 (1), pp. 240. Date of Electronic Publication: 2016 Oct 28.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.